Taichi Hatta

Kita, 4200881, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Oncologists' Views and Communication Practices Regarding Unproven High-Cost Cancer Interventions in Private Medical Practice: A Questionnaire Survey.

Oncologists' Views and Communication Practices Regarding Unproven High-Cost Cancer Interventions in Private Medical Practice: A Questionnaire Survey.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: October 25, 2025

Evolving determinants of implementing low-risk childbirth quality improvement in Japan: a longitudinal qualitative study.

Evolving determinants of implementing low-risk childbirth quality improvement in Japan: a longitudinal qualitative study.

Journal: BMC health services research

Published: June 28, 2025

Amendments to ASRM: Can we move away from a "Therapeutic Haven"?

Amendments to ASRM: Can we move away from a "Therapeutic Haven"?

Journal: Stem cell reports

Published: June 20, 2024

Safety of Combined Statin and Fibrate Therapy: Risks of Liver Injury and Acute Kidney Injury in a Cohort Study from the Shizuoka Kokuho Database.

Safety of Combined Statin and Fibrate Therapy: Risks of Liver Injury and Acute Kidney Injury in a Cohort Study from the Shizuoka Kokuho Database.

Journal: Drugs - real world outcomes

Published: April 22, 2024

The urgent need for clear and concise regulations on exosome-based interventions.

The urgent need for clear and concise regulations on exosome-based interventions.

Journal: Stem cell reports

Published: March 13, 2024

Does the Act on the Safety of Regenerative Medicine in Japan ensure "safety"?: Implications of low adverse event reporting.

Does the Act on the Safety of Regenerative Medicine in Japan ensure "safety"?: Implications of low adverse event reporting.

Journal: Stem cell reports

Published: September 05, 2023

Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan.

Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan.

Journal: Stem cell reports

Published: May 10, 2023

Human genome editing in clinical applications: Japanese lay and expert attitudes.

Human genome editing in clinical applications: Japanese lay and expert attitudes.

Journal: Frontiers in genetics

Published: April 13, 2023

Genome editing of human embryos for research purposes: Japanese lay and expert attitudes.

Genome editing of human embryos for research purposes: Japanese lay and expert attitudes.

Journal: Frontiers in genetics

Published: April 13, 2023

Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan.

Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan.

Journal: Stem cell reports

Published: August 31, 2022

Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study.

Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study.

Journal: BioPsychoSocial medicine

Published: April 09, 2022

Current status of cell-based interventions in Japan.

Current status of cell-based interventions in Japan.

Journal: Cell stem cell

Published: March 14, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026